Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.A charity warns today that it has just days left to raise £6m for an effective treatment for cystic fibrosis (CF) or a "once-in-a-lifetime opportunity" will be missed.
A shortfall in funding, caused by the economic slump, means that clinical trials to repair faulty genes in sufferers of the chronic lung disease could be axed. Early trials have shown that the treatment prevents lung damage caused by the disease, which affects 9,000 people in the UK.
The Cystic Fibrosis Trust has so far raised £1m this year. Gifts and guaranteed pledges are needed by the end of October for trial drugs to be ordered.
Professor Eric Alton, of the UK CF Gene Therapy Consortium, said: "A decade of work has put us in this position. No one else in the world is capable of doing this, and it is crucial for CF patients that we should push forward."
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments